Epidemiology of the metabolic syndrome in Hungary

Public Health

Volumn 126, Issue 2, 2012, Pages 143-149

  Szigethy, E ^a,b   Széles, Gy ^c   Horvath A ^d   Hidvegi T ^e   Jermendy, Gy ^f   Paragh, Gy ^b   Blaskó, Gy ^b   Adany R ^a,b   Voko Z ^c  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d Sanofi Aventis Zrt   (Hungary)

^e Petz Aladar County Teaching Hospital   (Hungary)

^f BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

Author keywords

Cross sectional study; Hungary; Metabolic syndrome; Prevalence

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CROSS SECTION; DISEASE PREVALENCE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGY; HEALTH RISK; MENS HEALTH; RISK FACTOR; WOMENS HEALTH;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ENVIRONMENTAL FACTOR; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUNGARY; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PHYSICAL EXAMINATION; PREVALENCE; PRIMARY HEALTH CARE; PUBLIC HEALTH; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HUNGARY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE;

HUNGARY;

EID: 84856585024     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2011.11.003     Document Type: Article

References (35)

1. Szeles G., Voko Z., Jenei T., Kardos L., Pocsai Z., Bajtay A., Papp E., Pásti G., Kósa Z., Molnár I., Lun K., Adány R. A preliminary evaluation of a health monitoring programme in Hungary. Eur J Public Health 2005, 15:26-32.
2. Kotseva K., Wood D., De Backer G., De Bacquer D., Pyorala K., Keil U. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009, 373:929-940.
3. Kiss C., Poor G., Donath J., Gergely P., Paksy A., Zajkas G., Antal M. Prevalence of obesity in an elderly Hungarian population. Eur J Epidemiol 2003, 18:653-657.
4. Vamos E.P., Kopp M.S., Keszei A., Novak M., Mucsi I. Prevalence of diabetes in a large, nationally representative population sample in Hungary. Diabetes Res Clin Pract 2008, 81:e5-e8.
5. Alberti K.G., Zimmet P., Shaw J. International Diabetes Federation: a consensus on type 2 diabetes prevention. Diabet Med 2007, 24:451-463.
6. Balkau B., Valensi P., Eschwege E., Slama G. A review of the metabolic syndrome. Diabetes Metab 2007, 33:405-413.
7. Obunai K., Jani S., Dangas G.D. Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am 2007, 91:1169-1184.
8. Taslim S., Tai E.S. The relevance of the metabolic syndrome. Ann Acad Med Singapore 2009, 38:29-33.
9. Grundy S.M. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008, 28:629-636.
10. Miccoli R., Bianchi C., Odoguardi L., Penno G., Caricato F., Giovannitti M.G., Pucci L., Del Prato S. Prevalence of the metabolic syndrome among Italian adults according to ATP III definition. Nutr Metab Cardiovasc Dis 2005, 15:250-254.
11. Balkau B., Vernay M., Mhamdi L., Novak M., Arondel D., Vol S., Tichet J., Eschwège E. D.E.S.I.R. Study Group. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabet Metab 2003, 29:526-532.
12. Matei C., Pop I., Jurcut R., Suceveanu M., Predescu D., Nechita E., Ionescu P., Ciovica D., Ginghina C. Romanian multicentric study of the prevalence of metabolic syndrome - ROMES. Hellenic J Cardiol 2008, 49:303-309.
13. Santos A.C., Barros H. Prevalence and determinants of obesity in an urban sample of Portuguese adults. Public Health 2003, 117:430-437.
14. Wittek A., Sokalski B., Grzeszczak W., Strojek K. Prevalence of diabetes and cardiovascular risk factors of industrial area in southern Poland. Exp Clin Endocrinol Diabetes 2009, 117:350-353.
15. Athyros V.G., Ganotakis E.S., Bathianaki M., Monedas I., Goudevenos I.A., Papageorgiou A.A., Papathanasiou A., Kakafika A.I., Mikhailidis D.P., Elisaf M. MetS-Greece Collaborative Group. Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study. Hellenic J Cardiol 2005, 46:380-386.
16. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Bonadonna R.C., Muggeo M. Bruneck Study. Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord 2003, 27:1283-1289.
17. Hollman G., Kristenson M. The prevalence of the metabolic syndrome and its risk factors in a middle-aged Swedish population - mainly a function of overweight?. Eur J Cardiovasc Nurs 2008, 7:21-26.
18. Kolcic I., Vorko-Jovic A., Salzer B., Smoljanovic M., Kern J., Vuletic S. Metabolic syndrome in a metapopulation of Croatian island isolates. Croat Med J 2006, 47:585-592.
19. Lorenzo C., Serrano-Rios M., Martinez-Larrad M.T., Gonzalez-Sanchez J.L., Seclen S., Villena A., Gonzalez-Villalpando C., Williams K., Haffner SM. Geographic variations of the international diabetes Federation and the National cholesterol Education Program-Adult treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care 2006, 29:685-691.
20. Kahn R., Buse J., Ferrannini E., Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289-2304.
21. Reaven G.M. The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr 2006, 83:1237-1247.
22. Grundy S.M. Does the metabolic syndrome exist?. Diabetes Care 2006, 29:1689-1692. discussion 93-6.
23. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment Panel III). JAMA 2001, 285:2486-2497.
24. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005, 366:1059-1062.
25. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C. International diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; World heart federation; international atherosclerosis society; international association for the study of obesity. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009, 120:1640-1645.
26. Day C. Metabolic syndrome, or what you will: definitions and epidemiology. Diab Vasc Dis Res 2007, 4:32-38.
27. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
28. Martinez M.A., Puig J.G., Mora M., Aragon R., O'Dogherty P., Anton J.L., Sánchez-Villares T., Rubio J.M., Rosado J., Torres R., Marcos J., Pallardo L.F., Banegas J.R. MAPA (Monitorización Ambulatoria de la Presión Arterial) Working Group. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) study. Metabolism 2008, 57:1232-1240.
29. Mokan M., Galajda P., Pridavkova D., Tomaskova V., Sutarik L., Krucinska L., Bukovská A., Rusnáková G. Prevalence of diabetes mellitus and metabolic syndrome in Slovakia. Diabetes Res Clin Pract 2008, 81:238-242.
30. Pitsavos C. The prevalence of the metabolic syndrome is high in Balkan countries. Hellenic J Cardiol 2008, 49:310-311.
31. Ádány R. Health status of the Hungarian population with special respect to the period after the turn of millennium. Népegészségügy 2008, 2:5-20. [in Hungarian].
32. Rurik I., Kalabay L. Primary healthcare in the developing part of Europe: changes and development in the former Eastern Bloc countries that joined the European Union following 2004. Med Sci Monit 2009, 15:PH78-PH84.
33. Jermendy G., Hetyesi K., Biro L., Hidvegi T. Prevalence of the metabolic syndrome in hypertensive and/or obese subjects. Diabet Med 2004, 21:805-806.
34. Csaszar A., Kekes E., Abel T., Papp R., Kiss I., Balogh S. Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population. Blood Press 2006, 15:101-106.
35. Kahn R., Robertson R.M., Smith R., Eddy D. The impact of prevention on reducing the burden of cardiovascular disease. Diabetes Care 2008, 31:1686-1696.